Patents by Inventor Isabelle Arnould

Isabelle Arnould has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8273548
    Abstract: The present invention relates to novel compounds and their uses, in particular their pharmaceutical or diagnostic uses or their use as pharmacological targets. More particularly, the present invention relates to a novel protein, referred to as PAP1, as well as to novel peptides and compounds which are capable of modulating, at least partially, the activity of parkin.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: September 25, 2012
    Assignee: Aventis Pharma S.A.
    Inventors: Han Koutnikova, Alexis Brice, Alain Fournier, Laurent Pradier, Catherine Prades, Isabelle Arnould-Reguigne, Marie-Fran├žoise Rosier-Montus, Olga Corti
  • Publication number: 20060287230
    Abstract: The present invention relates to novel compounds and their uses, in particular their pharmaceutical or diagnostic uses or their use as pharmacological targets. More particularly, the present invention relates to a novel protein, referred to as PAP1, as well as to novel peptides and compounds which are capable of modulating, at least partially, the activity of parkin.
    Type: Application
    Filed: March 28, 2006
    Publication date: December 21, 2006
    Inventors: Hana Koutnikova, Alexis Brice, Alain Fournier, Laurent Pradier, Catherine Prades, Isabelle Arnould-Reguigne, Marie-Francoise Rosier-Montus, Olga Corti
  • Patent number: 7132396
    Abstract: The present invention relates to novel compounds and their uses, in particular their pharmaceutical or diagnostic uses or their use as pharmacological targets. More particularly, the present invention relates to a novel protein, referred to as PAP1, as well as to novel peptides and compounds which are capable of modulating, at least partially, the activity of parkin.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: November 7, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Hana Koutnikova, Alexis Brice, Alain Fournier, Laurent Pradier, Catherine Prades, Isabelle Arnould-Reguigne, Marie-Fran├žoise Rosier-Montus, Olga Corti
  • Publication number: 20060063166
    Abstract: The present invention relates to a novel human ABCC12 gene as well as the cDNAs encoding the novel short and long of ABCC12 proteins isoforms. The invention also relates to vectors and recombinant host cells comprising such nucleic acids, nucleotide probes and primers, and means for the detection of polymorphisms and mutations in the ABCC12 gene or in the corresponding proteins isoforms produced by the allelic form of the ABCC12 gene.
    Type: Application
    Filed: December 16, 2004
    Publication date: March 23, 2006
    Applicant: Aventis Pharma S. A.
    Inventors: Marie Rosier, Catherine Prades, Isabelle Arnould, Michael Dean, Rando Allikmets, Patrice Denefle
  • Publication number: 20050158784
    Abstract: The present invention relates to nucleic acids corresponding to various exons of the ABCC11 gene as well as the cDNA encoding the novel full length of ABCC11 protein. The invention also relates to means for the detection of polymorphisms in general, and of mutations in particular, in the ABCC11 gene or in the corresponding protein produced by the allelic form of the ABCC11 gene.
    Type: Application
    Filed: January 12, 2005
    Publication date: July 21, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Marie Rosier, Catherine Prades, Isabelle Arnould, Michael Dean, Rando Allikmets, Patrice Denefle
  • Patent number: 6893841
    Abstract: The present invention relates to nucleic acids corresponding to various exons of the ABCC11 gene as well as the cDNA encoding the novel full length of ABCC11 protein. The invention also relates to means for the detection of polymorphisms in general, and of mutations in particular, in the ABCC11 gene or in the corresponding protein produced by the allelic form of the ABCC11 gene.
    Type: Grant
    Filed: March 5, 2002
    Date of Patent: May 17, 2005
    Assignee: Aventis Pharma S.A.
    Inventors: Marie Rosier, Catherine Prades, Isabelle Arnould, Michael Dean, Rando Allikmets, Patrice Denefle
  • Publication number: 20040185456
    Abstract: The invention relates to nucleic acids corresponding to different exons and introns of gene ABC1 which is shown to be a gene causing pathologies linked to cholesterol metabolism dysfunction causing diseases such as atherosclerosis, more particularly perturbation of reverse cholesterol transport and more particularly the FHD's such as Tangier Disease
    Type: Application
    Filed: June 18, 2003
    Publication date: September 23, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Patrice Denefle, Marie-Francoise Rosier-Montus, Isabelle Arnould-Reguigne, Catherine Prades, Laurent Naudin, Cendrine Lemoine, Nicolas Duverger, Stephan Rust, Gerd Assmann, Harald Funke, H. Bryan Brewer
  • Publication number: 20030087246
    Abstract: The present invention relates to a novel human ABCA12 gene as well as cDNAs encoding the novel full and short length ABCA12 proteins. The invention also relates to vectors and recombinants host cells comprising such nucleic acids, nucleotide probes and primers, and means for the detection of polymorphisms and mutations in the ABCA12 gene or in the corresponding protein produced by the allelic form of the ABCA12 gene.
    Type: Application
    Filed: February 12, 2002
    Publication date: May 8, 2003
    Inventors: Isabelle Arnould-Reguigne, Catherine Prades, Laurent Naudin, Cendrine Lemoine, Michael Dean, Patrice Denefle, Marie-Francoise Rosier-Montus
  • Publication number: 20030077605
    Abstract: The present invention relates to a novel human ABCC12 gene as well as the cDNAs encoding the novel short and long of ABCC12 proteins isoforms. The invention also relates to vectors and recombinant host cells comprising such nucleic acids, nucleotide probes and primers, and means for the detection of polymorphisms and mutations in the ABCC12 gene or in the corresponding proteins isoforms produced by the allelic form of the ABCC12 gene.
    Type: Application
    Filed: March 5, 2002
    Publication date: April 24, 2003
    Inventors: Marie Rosier, Catherine Prades, Isabelle Arnould, Michael Dean, Rando Allikmets, Patrice Denefle
  • Publication number: 20030077591
    Abstract: The present invention relates to nucleic acid sequences that regulate the transcription of the ABCA7 gene, which may be involved in the metabolism of lipids in hematopoietic tissues, as well as in cell signaling mechanisms linked to the immune reaction and to inflammation. The invention also relates to polypeptides and polynucleotides that may be involved in diseases associated with the genetic locus q13 of chromosome 19.
    Type: Application
    Filed: October 24, 2001
    Publication date: April 24, 2003
    Inventors: Patrice Denefle, Marie-Francoise Rosier-Montus, Catherine Prades, Isabelle Arnould-Reguigne, Jose Osorio Y Fortea, Nicolas Duverger, Giovanna Chimini
  • Publication number: 20030059793
    Abstract: The present invention relates to nucleic acids corresponding to various exons of the ABCC11 gene as well as the cDNA encoding the novel full length of ABCC11 protein. The invention also relates to means for the detection of polymorphisms in general, and of mutations in particular, in the ABCC11 gene or in the corresponding protein produced by the allelic form of the ABCC11 gene.
    Type: Application
    Filed: March 5, 2002
    Publication date: March 27, 2003
    Inventors: Marie Rosier, Catherine Prades, Isabelle Arnould, Michael Dean, Rando Allikmets, Patrice Denefle
  • Publication number: 20030056234
    Abstract: The present invention relates to isolated nucleic acids encoding the ABCA1 transporter protein and comprising polymorphic sequence variations, and to peptides which are derived from the human ABCA1 transporter and which contain polymorphic amino acids.
    Type: Application
    Filed: October 31, 2001
    Publication date: March 20, 2003
    Inventors: Patrice Denefle, Marie-Francoise Rosier-Montus, Isabelle Arnould-Reguigne, Nicolas Duverger, Francois Cambien
  • Publication number: 20030044895
    Abstract: The present invention relates to nucleic acids corresponding to various exons of ABCA5, ABCA6, ABCA9, and ABCA10 genes as well as cDNAs encoding the novel full length of ABCA5, ABCA6, ABCA9, and ABCA10 proteins. The invention also relates to means for the detection of polymorphisms in general, and of mutations in particular, in the ABCA5, ABCA6, ABCA9, and ABCA10 genes or in the corresponding protein produced by the allelic form of the ABCA5, ABCA6, ABCA9, and ABCA10 genes.
    Type: Application
    Filed: December 7, 2001
    Publication date: March 6, 2003
    Inventors: Patrice Denefle, Marie-Francoise Rosier-Montus, Catherine Prades, Isabelle Arnould-Reguigne, Nicolas Duverger, Rando Allikmets, Michael Dean
  • Publication number: 20020155577
    Abstract: The present invention relates to novel compounds and their uses, in particular their pharmaceutical or diagnostic uses or their use as pharmacological targets. More particularly, the present invention relates to a novel protein, referred to as PAP1, as well as to novel peptides and compounds which are capable of modulating, at least partially, the activity of parkin.
    Type: Application
    Filed: February 20, 2001
    Publication date: October 24, 2002
    Inventors: Hana Koutnikova, Alexis Brice, Alain Fournier, Laurent Pradier, Catherine Prades, Isabelle Arnould-Reguigne, Marie-Francoise Rosier-Montus, Olga Corti